What’s with the 4DMedical (ASX:4DX) share price today?

The 4DMedical (ASX: 4DX) share price has dipped early this afternoon after 2 major announcements from the company. Let’s take a look.
The post What’s with the 4DMedical (ASX:4DX) share price today? appeared first on The Motley Fool Australia. –

Woman in mustard yellow blouse on laptop holds both hands out to either side with graphic illustration of question marks above them

The 4DMedical Ltd (ASX: 4DX) share price shot up 4.6% in opening today before falling into the red early this afternoon. This, after the medical technology company announced it had received a government grant and would begin a capital raising program.

The 4DMedical share price opened at $1.81, up 8 cents on yesterday’s close but has since retreated to $1.73, putting it flat at the time of writing.

Shares in the company were placed in voluntary suspension for 2 days earlier this week, in anticipation of the news.

Why is the 4D Medical share price moving today?

In today’s release, the company announced a consortium led by 4DMedical, the Australian Lung Health Initiative (ALHI), has been awarded a $28.9 million federal government grant.  The company said the cash will be used to develop “the world’s first” lung function scanners to provide “safe, easy and rapid lung analysis” for both adults and children.

The grant is a part of the Federal Government’s Medical Research Future Fund (MRFF) – a $20 billion program aiming to “transform health and medical research”. The government will allocate the funding over a 5-year period.

4DMedical has exclusive commercial rights for the XVD Scanners – including intellectual property rights. The medical technology company will receive 100% of the revenue from scanner sales.

In conjunction with the grant, 4DMedical will also complete a $40 million capital raising project. It will list 25.8 million new shares on the ASX at a price of $1.55 each. Existing shareholders will be able to apply for these shares, too. The cap for new shares for existing shareholders is a $30,000 value.

The company expects trading of new shares to begin 15 March. The issuance will occur on 7 April.

Words from the CEO

Commenting on the MRFF funding, 4DMedical founder and CEO, Andreas Fouras, said:

We’re thrilled with the huge vote of confidence afforded by the competitive assessment process, as we aim to deliver safe and accurate lung health technology to those who need it. I thank our partners on this project for their outstanding support as we look forward to bringing this Australian innovation to fruition.

[The capital raising initiative] will provide us with the funds needed to execute the long-term commercialisation strategy for XVD Scanners, which will open up an additional revenue stream for the business…

…[It] also provides us with balance sheet flexibility for future growth opportunities that can accelerate the commercialisation of the XV LVAS product…

The company estimates the lung diagnostics market at $40 billion a year.

4DMedical share price snapshot

This time last year, the 4DMedical share price was swapping hands at $1.59. At today’s price that calculates at 8.49% growth. However, the 4DMedical share price has been trending downwards for the year-to-date. The share price in the new year was $2.44 – representing a 29.3% fall.

4DMedical’s market capitalisation is $307 million.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor Marc Sidarous has no position in any of the shares mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post What’s with the 4DMedical (ASX:4DX) share price today? appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!